Works matching IS 00099236 AND DT 2020 AND VI 107 AND IP 2
Results: 24
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 310, doi. 10.1002/cpt.1727
- Publication type:
- Article
In this Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 303, doi. 10.1002/cpt.1726
- Publication type:
- Article
Finding New Drugs for Infectious Diseases: Development Times and Success Rates.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 305, doi. 10.1002/cpt.1728
- By:
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 308, doi. 10.1002/cpt.1725
- Publication type:
- Article
Risk of Myocardial Infarction Among New Users of Calcium Supplements Alone or Combined With Vitamin D: A Population‐Based Case‐Control Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 359, doi. 10.1002/cpt.1636
- By:
- Publication type:
- Article
The Self‐Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 321, doi. 10.1002/cpt.1631
- By:
- Publication type:
- Article
Response to "The Self‐Controlled Case Series Design as a Viable Alternative to Studying Clinically Relevant Drug Interactions".
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 323, doi. 10.1002/cpt.1630
- By:
- Publication type:
- Article
Early Tacrolimus Concentrations After Lung Transplant Are Predicted by Combined Clinical and Genetic Factors and Associated With Acute Kidney Injury.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 462, doi. 10.1002/cpt.1629
- By:
- Publication type:
- Article
Long‐Chain Polyphosphate Is a Potential Agent for Inducing Mucosal Healing of the Colon in Ulcerative Colitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 452, doi. 10.1002/cpt.1628
- By:
- Publication type:
- Article
Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 324, doi. 10.1002/cpt.1627
- By:
- Publication type:
- Article
Secondary Stroke Prevention: A Population‐Based Cohort Study on Anticoagulation and Antiplatelet Treatments, and the Risk of Death or Recurrence.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 443, doi. 10.1002/cpt.1625
- By:
- Publication type:
- Article
Meta‐Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 435, doi. 10.1002/cpt.1624
- By:
- Publication type:
- Article
A Minimal Physiologically‐Based Pharmacokinetic Model Demonstrates Role of the Neonatal Fc Receptor (FcRn) Competition in Drug–Disease Interactions With Antibody Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 423, doi. 10.1002/cpt.1619
- By:
- Publication type:
- Article
Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 347, doi. 10.1002/cpt.1618
- By:
- Publication type:
- Article
Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 415, doi. 10.1002/cpt.1616
- By:
- Publication type:
- Article
DNL104, a Centrally Penetrant RIPK1 Inhibitor, Inhibits RIP1 Kinase Phosphorylation in a Randomized Phase I Ascending Dose Study in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 406, doi. 10.1002/cpt.1615
- By:
- Publication type:
- Article
Next Challenge From the Variance in Individual Physiologically‐Based Pharmacokinetic Model‐Predicted to Observed Morphine Concentration in Critically Ill Neonates.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 319, doi. 10.1002/cpt.1607
- By:
- Publication type:
- Article
Intersubject and Intrasubject Variability of Potential Plasma and Urine Metabolite and Protein Biomarkers in Healthy Human Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 397, doi. 10.1002/cpt.1606
- By:
- Publication type:
- Article
Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV‐Infected Women.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 315, doi. 10.1002/cpt.1605
- By:
- Publication type:
- Article
Autoimmune Effects of Lung Cancer Immunotherapy Revealed by Data‐Driven Analysis on a Nationwide Cohort.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 388, doi. 10.1002/cpt.1597
- By:
- Publication type:
- Article
Exposure–Response Relationships for Efficacy and Safety of Risankizumab in Phase II and III Trials in Psoriasis Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 378, doi. 10.1002/cpt.1594
- By:
- Publication type:
- Article
Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 369, doi. 10.1002/cpt.1586
- By:
- Publication type:
- Article
Next‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 333, doi. 10.1002/cpt.1571
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 2, p. 295, doi. 10.1002/cpt.1518
- Publication type:
- Article